Celebrex Class Action Suits – Regaining Power For The People
By Dave Hoffman
The first Celebrex class action suit to be filed is believed to be the one submitted in Illinois, in December 2004. That same month, Pfizer announced that a recently performed clinical trial revealed that those taking Celebrex were at increased risk - over two times that incurred by taking a placebo - of experiencing a major cardiovascular episode. It would seem that the Illinois class action suit will be only the first of many. And yet Celebrex remains on the market. Most drugs that we take are liable to have a wide range of potential side effects, most of which the majority of patients will never experience. For liability purposes, pharmaceutical companies print all conceivable side effects on their informational literature, and reading these before taking a medication can be a nerve-wracking affair. But even side effects that have been encountered by minimal numbers of people during clinical trials can find their way on to this literature, and while you may be one of the unlucky ones whose painkiller causes nausea, in most of these cases, the potential benefits far outweigh the unlikely event of developing a minor side effect that will cease once the medication has been stopped. It is a similar argument that has been used in keeping Celebrex on the market - that the side effects encountered by some should not deny others the benefits that the drug has to offer. Used commonly as an anti-inflammatory and painkiller for conditions such as arthritis, it is understandable that this would be an attractive drug to many. But surely not when the side effect price is so high. Rigorous clinical trials are performed on drugs before they reach the marketplace, but even these cannot predict all the various implications of using a drug in longevity. But it seems that there are too many highly effective drugs available today that cause life threatening side effects - Celebrex is only one of these. Patients surely must be asking themselves whether pharmaceutical companies are rushing apparently effective drugs to the marketplace without ensuring that they are completely safe for long-term use. Patients are responding in the only way that can really touch these companies, in this case Pfizer: by filing Celebrex class action suits.
About the author:
Dave Hoffman is the founder of http://www.celebrex-class-action-suit.comWe provide a free service that connects you with attorneys specializing in Clebrex Law.
By Revealing Man's Past, Lawyer Tests Court Secrecy New York Times In May 2010, a civil racketeering lawsuit was filed accusing a group of people associated with a New York investment firm of stealing millions of dollars from investors. The allegation was almost commonplace; the response was anything but.
Comics: Justice League fights real-world hunger The Seattle Times Batman, Superman, Wonder Woman and the rest of the Justice League will be used to raise awareness, not to mention millions of dollars. Both of which are needful. According to DC, the Horn countries are suffering their worst drought in more than 60 ...
Teacher arrests show 'complete failure' at LA school, attorney says Los Angeles Times Accusations by a student at Miramonte Elementary School that she was a victim of two teachers accused of abuse raises troubling questions about oversight at the school, the attorney for her family said. “Based on my experience, it appears to show a ...
Sloan-Kettering Chief Is Accused of Taking Research New York Times Yale, for example, won more than $1 million in compensation and legal fees in 2005 from a Nobel laureate it had accused of taking its technology. But the lawsuit against Dr. Thompson has particularly high stakes, potentially affecting the reputations ...
